Table 1.
Population characteristics: Study population compared to South African Census 2011
| Study Population 2016 2017 | South Africa Census 2011 | |
|---|---|---|
| Unique Individuals | 2,638,955 | 51,764,899 |
| Wards | 1427 | 4277 |
| Districts | 52 | 52 |
| Provinces | 9 | 9 |
| Sex | ||
| Female | 1,459,269 (55.3%) | 26,579,527 (51.3%) |
| Population Groups | ||
| Black African | 1,743,515 (66.1%) | 40,996,454 (79.2%) |
| Indian/Asian | 102,229 (3.9%) | 1,286,789 (2.5%) |
| Coloured | 203,298 (7.7%) | 4,614,896 (8.9%) |
| White | 530,274 (20.1%) | 4,586,336 (8.9%) |
| Unknown | 59,639 (2.3%) | 280,423 (0.5%) |
| Age Bands | ||
| 00–04 | 251,838 (9.5%) | 5,684,973 (11.0%) |
| 05–09 | 277,237 (10.5%) | 4,819,353 (9.3%) |
| 10–14 | 257,808 (9.8%) | 4,594,492 (8.9%) |
| 15–19 | 245,690 (9.3%) | 5,003,087 (9.7%) |
| 20–24 | 94,063 (3.6%) | 5,374,063 (10.4%) |
| 25–29 | 112,642 (4.3%) | 5,058,738 (9.8%) |
| 30–34 | 180,821 (6.9%) | 4,028,532 (7.8%) |
| 35–39 | 186,664 (7.1%) | 3,467,343 (6.7%) |
| 40–44 | 205,362 (7.8%) | 2,948,218 (5.7%) |
| 45–49 | 209,260 (7.9%) | 2,619,908 (5.1%) |
| 50–54 | 192,386 (7.3%) | 2,217,920 (4.3%) |
| 55–59 | 152,690 (5.8%) | 1,797,131 (3.5%) |
| 60–64 | 99,006 (3.8%) | 1,385,535 (2.7%) |
| 65–69 | 66,348 (2.5%) | 957,668 (1.9%) |
| 70–74 | 46,011 (1.7%) | 748,204 (1.4%) |
| 75–79 | 30,855 (1.2%) | 481,216 (0.9%) |
| 80–84 | 17,575 (0.7%) | 322,870 (0.6%) |
| 85+ | 12,699 (0.5%) | 255,648 (0.5%) |
| Province | ||
| Eastern Cape | 292,154 (11.1%) | 6,560,024 (12.7%) |
| Free State | 221,538 (8.4%) | 2,745,290 (5.3%) |
| Gauteng | 557,680 (21.1%) | 12,271,736 (23.7%) |
| KwaZulu-Natal | 458,618 (17.4%) | 10,266,802 (19.8%) |
| Limpopo | 260,984 (9.9%) | 5,404,032 (10.4%) |
| Mpumalanga | 252,359 (9.6%) | 4,039,488 (7.8%) |
| North West | 194,919 (7.4%) | 3,509,672 (6.8%) |
| Northern Cape | 83,159 (3.2%) | 1,145,529 (2.2%) |
| Western Cape | 317,544 (12.0%) | 5,822,326 (11.2%) |
| Exposure | ||
| Average membership months per year | 11.8 | – |
| Morbidity status | ||
| ACG risk score / Comorbidity index (CMI) | 0.998 | – |